Target intelligence / Profile preview

Fibrous sheath-interacting protein 2 (FSIP2)

Target
FSIP2
Molecular classification
Other (structural protein, component of sperm fibrous sheath)
01

Overview

Fibrous sheath-interacting protein 2 (FSIP2) is a large structural protein (full length: 6907 amino acids) that is specifically expressed in the testis and is a principal component of the sperm fibrous sheath, a cytoskeletal structure crucial for proper flagellar morphology and motility. FSIP2 is essential for assembling the sperm tail, including the fibrous sheath and mitochondrial sheath, and also plays a role in acrosome formation and sperm-egg recognition. Mutations in FSIP2 cause severe morphological defects in sperm flagella (including axonemal and fibrous sheath disorganization and abnormal mitochondrial sheath elongation), resulting in asthenoteratozoospermia and male infertility (MMAF). FSIP2 interacts with several other sperm-specific proteins, including AKAP4 and Acrv1, and disrupted FSIP2 impairs protein–protein interactions necessary for flagellar assembly and function. There is also some evidence for FSIP2 gene amplification in testicular germ cell tumors. FSIP2 has no currently identified drug interactions or mechanism of action as it is not a therapeutic/druggable target.

Other names
FLJ34780SPGF34fibrous sheath-interacting protein 2
02

Biological functions

Sperm flagellum assemblySpermatogenesisAcrosome formation
03

Disease associations

Male infertility (especially multiple morphological abnormalities of the sperm flagella, MMAF)Potential association with testicular germ cell tumors
04

Safety considerations

Loss-of-function mutations lead to male infertility (MMAF)No known direct safety concerns as a therapeutic target, as it is not drugged

Beyond the preview

Go deeper on Fibrous sheath-interacting protein 2 (FSIP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibrous sheath-interacting protein 2 (FSIP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call